Health
Results: 1501-1512 of 7446

ZINZINO AB (PUBL.): ZINZINO INITIATES NEGOTIATIONS FOR PART OWNERSHIP IN ANDORRA-BASED XION INTERNATIONAL GROUP FOR FURTHER DEVELOPMENT OF PROPRIETARY OMEGA-3 OIL AND SPIRULINA

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members

Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1

Samsung Bioepis' European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines





